4//SEC Filing
SCHAFFER DERACE L 4
Accession 0001012975-17-000916
CIK 0001326190other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:34 PM ET
Size
9.8 KB
Accession
0001012975-17-000916
Insider Transaction Report
Form 4
SCHAFFER DERACE L
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2017-12-04$1.81/sh+7,300$13,195→ 307,673 total - Purchase
Common Stock, par value $0.0001
2017-12-01$1.80/sh+5,215$9,405→ 300,373 total - Purchase
Common Stock, par value $0.0001
2017-12-05$1.78/sh+13,495$23,987→ 321,168 total
Holdings
- 12,393(indirect: By IRA)
Common Stock, par value $0.0001
Footnotes (3)
- [F1]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.78 to $1.82 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
- [F2]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.78 to $1.84 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
- [F3]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.68 to $1.88 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001031735
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:34 PM ET
- Size
- 9.8 KB